TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9139555

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 70
Study: 10146966

Group type: EXPERIMENTAL
Intervention: Oral mesalazine (mesalamine) at 1g, 2g, or 4g daily
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study: 3003144

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31563122

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (artificially flavored)
Number of subjects: 17
Study: 29531764

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27428073

Group type: EXPERIMENTAL
Intervention: Autologous tumour lysate dendritic cell vaccine (ADC) + best supportive care (BSC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Immunization with ADC
Number of subjects: 52
Study: 25498484

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) treatment initiated within 3 hours of injury
Number of subjects: 20211

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) treatment initiated beyond 3 hours of injury
Number of subjects: 20211
Study: 23424892

Group type: EXPERIMENTAL
Intervention: Corn tortilla fortified with 20 mg/kg of zinc oxide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Corn tortilla fortified with 20 mg/kg of zinc sulfate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Unfortified corn tortilla
Number of subjects: 10

Group type: COMPARATOR
Intervention: Corn tortilla with no iron added
Number of subjects: 10

Group type: COMPARATOR
Intervention: Corn tortilla with 30 mg/kg of iron added
Number of subjects: 10

Group type: COMPARATOR
Intervention: Corn tortilla with 60 mg/kg of iron added
Number of subjects: 10
Study: 20450653

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 18715434

Group type: EXPERIMENTAL
Intervention: Cocoa butter lotion
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 210
Study: 20428365

Group type: EXPERIMENTAL
Intervention: Ivermectin treatment for all household members
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 132
Study: 16354359

Group type: EXPERIMENTAL
Intervention: Radiosurgical excision
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cold knife excision
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 12040811

Group type: EXPERIMENTAL
Intervention: Mentoring program
Number of subjects: 0
Study: 9845867

Group type: EXPERIMENTAL
Intervention: Node-link mapping enhanced counseling
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 360
Study: 7985509

Group type: EXPERIMENTAL
Intervention: Regular attenders (Group A)
Number of subjects: 8310

Group type: EXPERIMENTAL
Intervention: Gold restorations
Number of subjects: 8310

Group type: EXPERIMENTAL
Intervention: Amalgam restorations
Number of subjects: 8310

Group type: EXPERIMENTAL
Intervention: Composite resin restorations
Number of subjects: 8310

Group type: COMPARATOR
Intervention: All restorations
Number of subjects: 8310
Study: 2661435

Group type: EXPERIMENTAL
Intervention: CGP 38560A 50 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CGP 38560A 125 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CGP 38560A 250 micrograms/kg
Number of subjects: 15
Study: 31422414

Group type: EXPERIMENTAL
Intervention: 5-gene combination
Number of subjects: 19
Study: 29573538

Group type: EXPERIMENTAL
Intervention: Physiotherapist (PT) follow-up
Number of subjects: 68

Group type: COMPARATOR
Intervention: Rheumatologist (RT) follow-up
Number of subjects: 68
Study: 27080120

Group type: EXPERIMENTAL
Intervention: Same-day ART initiation
Number of subjects: 260

Group type: COMPARATOR
Intervention: Standard of care pre-ART assessment and counselling
Number of subjects: 260
Study: 23253191

Group type: EXPERIMENTAL
Intervention: ModNa(+) (82 mM Na+)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HighNa(+) (164 mM Na+)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON (water alone)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ModNa(+) and HighNa(+)
Number of subjects: 10
Study: 22288920

Group type: EXPERIMENTAL
Intervention: 1 N tongue training
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 3 N tongue training
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TDS training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control experiment (experienced group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control experiment (naive group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TDS training vs simple tongue training
Number of subjects: 16
Study: 20943454

Group type: EXPERIMENTAL
Intervention: CON‐IFN plus lamivudine combination therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: lamivudine monotherapy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEG‐IFN plus lamivudine combination therapy
Number of subjects: 9
Study: 17227819

Group type: EXPERIMENTAL
Intervention: Acute normovolaemic haemodilution (ANH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 16114156

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg once daily (n=125)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Perindopril 4 mg daily (n=125)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 250

Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 250
Study: 11950109

Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 55

Group type: COMPARATOR
Intervention: Bottle-feeding
Number of subjects: 55
Study: 10069877

Group type: EXPERIMENTAL
Intervention: Asthma Outreach Program (AOP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (single intensive asthma education intervention)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison of AOP vs Control
Number of subjects: 57
Study: 7732341

Group type: EXPERIMENTAL
Intervention: Attendance in screening for colorectal cancer with faecal occult blood testing
Number of subjects: 34144

Group type: EXPERIMENTAL
Intervention: Non-attenders
Number of subjects: 34144

Group type: EXPERIMENTAL
Intervention: Attenders
Number of subjects: 34144
Study: 2325572

Group type: EXPERIMENTAL
Intervention: Low-dose calcitriol (0.25 micrograms twice daily)
Number of subjects: 636

Group type: COMPARATOR
Intervention: Calcium supplementation (1,000 mg/d)
Number of subjects: 636
Study: 6997734

Group type: EXPERIMENTAL
Intervention: Single intramuscular dose of aqueous penicillin G given at birth
Number of subjects: 18738
Study: 31772545

Group type: EXPERIMENTAL
Intervention: Slender sheath
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard sheath
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1000
Study: 24866894

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.6µg/kg/hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 60
Study: 25636764

Group type: EXPERIMENTAL
Intervention: Radiation therapy with irradiation to the internal mammary lymph node (IMN) (Arm 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation therapy without irradiation to the internal mammary lymph node (IMN) (Arm 1)
Number of subjects: 0
Study: 24781178

Group type: EXPERIMENTAL
Intervention: Tonsilgon N (herbal preparation)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no herbal preparation)
Number of subjects: 62
Study: 22113496

Group type: EXPERIMENTAL
Intervention: Celecoxib (COX-2 inhibitor)
Number of subjects: 3
Study: 19205027

Group type: EXPERIMENTAL
Intervention: SPIRIT intervention
Number of subjects: 58
Study: 17293547

Group type: EXPERIMENTAL
Intervention: Breastfeeding peer counseling (PC) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15339467

Group type: EXPERIMENTAL
Intervention: Granules for nourishing kidney and strengthening brain (GNKSB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Piracetam
Number of subjects: 90
Study: 12080353

Group type: COMPARATOR
Intervention: 8 liters leukapheresis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 12 liters leukapheresis
Number of subjects: 40
Study: 9833917

Group type: EXPERIMENTAL
Intervention: Packed red cells
Number of subjects: 16

Group type: COMPARATOR
Intervention: Protein solution
Number of subjects: 16
Study: 8125392

Group type: EXPERIMENTAL
Intervention: Enteral feeding for 15 days
Number of subjects: 98

Group type: COMPARATOR
Intervention: Parenteral feeding for 15 days
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 98
Study: 2573444

Group type: EXPERIMENTAL
Intervention: MK‐912 2.0 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MK‐912 1.0 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 795007

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg i.v. per day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Benzylpenicillin 10 million I.U. 4 times a day and streptomycin 500 mg twice a day
Number of subjects: 57
Study: 31770081

Group type: EXPERIMENTAL
Intervention: Red wine (3 units/day for 2 weeks)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Vodka (3 units/day for 2 weeks)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Comparison between red wine and vodka
Number of subjects: 77
Study: 30625297

Group type: EXPERIMENTAL
Intervention: NVR 3-778 plus pegIFN (600 mg twice daily)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: NVR 3-778 (≥1200 mg/d)
Number of subjects: 73

Group type: COMPARATOR
Intervention: NVR 3-778 (100 mg, 200 mg, or 400 mg daily)
Number of subjects: 73

Group type: COMPARATOR
Intervention: pegIFN alone
Number of subjects: 73
Study: 28190122

Group type: EXPERIMENTAL
Intervention: Anterolateral incision
Number of subjects: 20

Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 20
Study: 25790848

Group type: EXPERIMENTAL
Intervention: MyPACE (acne-related questions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (non-dermatologic health-related questions)
Number of subjects: 50
Study: 23480696

Group type: EXPERIMENTAL
Intervention: Pre-emptive triple analgesia (n = 55)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control (n = 80)
Number of subjects: 135
Study: 21854365

Group type: EXPERIMENTAL
Intervention: Single port laparoscopically assisted vaginal hysterectomy (SP-LAVH)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Conventional multiport laparoscopically assisted vaginal hysterectomy (conventional LAVH)
Number of subjects: 95
Study: 19571727

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: SIB-8
Number of subjects: 875
Study: 17426275

Group type: EXPERIMENTAL
Intervention: 100 mg hydrocortisone
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Hydrocortisone and Placebo
Number of subjects: 241
Study: 15274404

Group type: EXPERIMENTAL
Intervention: Cisplatin-gemcitabine (CG) - gemcitabine 1125 mg/m2 (days 1 and 8) plus cisplatin 80 mg/m2 (day 2) every 3 weeks for a maximum of 5 cycles
Number of subjects: 69

Group type: COMPARATOR
Intervention: Epirubicin-gemcitabine (EG) - gemcitabine 1125 mg/m2 (days 1 and 8) plus epirubicin 100 mg/m2 (day 1) every 3 weeks for a maximum of 5 cycles
Number of subjects: 69
Study: 11534915

Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.02%
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (vehicle control)
Number of subjects: 2
Study: 9807989

Group type: EXPERIMENTAL
Intervention: Interferon alpha2b plus ribavirin for 48 weeks
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Interferon alpha2b plus ribavirin for 24 weeks
Number of subjects: 832

Group type: COMPARATOR
Intervention: Interferon alpha2b plus placebo for 48 weeks
Number of subjects: 832
Study: 7700785

Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac sodium and bupivacaine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride (alone)
Number of subjects: 0
Study: 2791714

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g single pre‐operative dose, continued daily for 5 days in perforated appendicitis)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Triple regimen (metronidazole, gentamicin, and ampicillin, given every 8 hours for 3 days, extended to 5-7 days in cases of perforation)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Triple regimen
Number of subjects: 200
Study: 196421

Group type: EXPERIMENTAL
Intervention: LUPIDON H or LUPIDON G
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30922885

Group type: EXPERIMENTAL
Intervention: Nine-point Likert scale
Number of subjects: 57

Group type: COMPARATOR
Intervention: Three-point Likert scale
Number of subjects: 57
Study: 27967281

Group type: EXPERIMENTAL
Intervention: 6.4% maltodextrin solution (MAL)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 7.1% glucose solution (GLU)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Water (W)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Artificially sweetened solution (PLA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control trial with no rinse (CON)
Number of subjects: 18
Study: 25557776

Group type: EXPERIMENTAL
Intervention: Biofeedback training twice daily for 5 days, concurrent with CPM therapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no biofeedback intervention)
Number of subjects: 66
Study: 23158522

Group type: EXPERIMENTAL
Intervention: Everolimus 4.5 mg/m² per day (titrated to achieve blood trough concentrations of 5-15 ng/mL)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 117
Study: 22082247

Group type: EXPERIMENTAL
Intervention: Redesigning Daily Occupations program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Care as Usual
Number of subjects: 42
Study: 19525739

Group type: EXPERIMENTAL
Intervention: Combination therapy (CT) - antidepressants and body‐mind‐spirit group psychotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monotherapy (MT) - antidepressants only
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination therapy (CT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monotherapy (MT)
Number of subjects: 36
Study: 16755179

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 471

Group type: COMPARATOR
Intervention: Control group (no intervention during pre-test)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Pretest characteristics (married, employed, worried about breast cancer, received annual physical examination)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Age groups
Number of subjects: 471
Study: 15774356

Group type: EXPERIMENTAL
Intervention: Experiential Training
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rational Training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 50
Study: 15577166

Group type: EXPERIMENTAL
Intervention: Increased dietary calcium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11198056

Group type: EXPERIMENTAL
Intervention: Dothiepin 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9331213

Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 79

Group type: COMPARATOR
Intervention: Acrylic IOL
Number of subjects: 79
Study: 8447614

Group type: EXPERIMENTAL
Intervention: Enteral feeding for three days
Number of subjects: 62

Group type: COMPARATOR
Intervention: No enteral feeding for three days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Second randomisation to enteral feeding for three days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Second randomisation to no enteral feeding for three days
Number of subjects: 62
Study: 3828485

Group type: EXPERIMENTAL
Intervention: Propranolol administered rectally (80 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propranolol administered orally (80 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propranolol administered intravenously (2.2 mg)
Number of subjects: 8
Study: 2910963

Group type: EXPERIMENTAL
Intervention: Narrow excision (1-cm margins)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Wide excision (3 cm or more margins)
Number of subjects: 612
Study: 31054062

Group type: EXPERIMENTAL
Intervention: Intercessory prayer
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 31
Study: 31394146

Group type: EXPERIMENTAL
Intervention: ARK intervention (Antibiotic Review Kit)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Pre-implementation
Number of subjects: 588
Study: 28397981

Group type: EXPERIMENTAL
Intervention: Endometrial injury on cycle day 15-24
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 105
Study: 26486868

Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator 0.9 mg/kg
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Blood pressure-lowering treatment during the first 24 hours
Number of subjects: 3035

Group type: COMPARATOR
Intervention: High baseline blood pressure and high blood pressure variability
Number of subjects: 3035
Study: 23964813

Group type: EXPERIMENTAL
Intervention: Mentalization training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Didactic training
Number of subjects: 48
Study: 21402563

Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Conventional therapy
Number of subjects: 635
Study: 19711188

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 61
Study: 17341170

Group type: EXPERIMENTAL
Intervention: Interferon-β1b
Number of subjects: 0
Study: 15488777

Group type: EXPERIMENTAL
Intervention: Vitreous presentation (VP) with posterior chamber (PC) intraocular lens (IOL)
Number of subjects: 751

Group type: COMPARATOR
Intervention: Nonvitreous presentation (NVP)
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Vitreous presentation (VP)
Number of subjects: 751
Study: 11450583

Group type: EXPERIMENTAL
Intervention: New paracentesis needle
Number of subjects: 45

Group type: COMPARATOR
Intervention: Angiocath
Number of subjects: 45
Study: 14518310

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy with 5-FU (1000 mg/m2 continuously over 5d/28d) and Folinic Acid (200 mg/m2 over 15 minutes 5d/28d)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Resection only (Control)
Number of subjects: 226
Study: 7912249

Group type: EXPERIMENTAL
Intervention: 600 mg/day of ursodeoxycholic acid (Group A: 18 patients)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (Group B: 18 patients)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 2574656

Group type: EXPERIMENTAL
Intervention: Operative management (surgery)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in Crohn's colitis
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conservative treatment in Crohn's colitis
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in ileocolitis
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conservative treatment in ileocolitis
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in ileitis
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conservative treatment in ileitis
Number of subjects: 205
Study: 1092533

Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hydrophilic colloid
Number of subjects: 8
Study: 30596892

Group type: EXPERIMENTAL
Intervention: Surrogate intervention recovery of a DAG (sirDAG)
Number of subjects: 550
Study: 28388220

Group type: EXPERIMENTAL
Intervention: One-day sleep workshop for insomnia
Number of subjects: 14
Study: 28286287

Group type: EXPERIMENTAL
Intervention: Capecitabine-based treatment
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Capecitabine in combination with oxaliplatin and bevacizumab
Number of subjects: 1973
Study: 26251016

Group type: EXPERIMENTAL
Intervention: Filgrastim 2.5 µg/kg/day for 7 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Filgrastim 5 µg/kg/day for 7 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Filgrastim 10 µg/kg/day for 5 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: BK0023 (all doses)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 90
Study: 23240876

Group type: EXPERIMENTAL
Intervention: GaAlAs laser light (830 nm, 100mW, 22 sec on vestibular and palatal surfaces)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo control (laser light off)
Number of subjects: 60
Study: 21447912

Group type: EXPERIMENTAL
Intervention: Low frequency (1 Hz) rTMS applied to the anterior portion of a Broca's area homologue for 20 minutes per day for 10 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12
Study: 19188371

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention
Number of subjects: 189

Group type: COMPARATOR
Intervention: Case management
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard provider care
Number of subjects: 189
Study: 14990833

Group type: EXPERIMENTAL
Intervention: Adrenal hematoma patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 51
Study: 11555104

Group type: EXPERIMENTAL
Intervention: HBsAg stimulation of PBMC
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: CD8+ T cell deletion
Number of subjects: 4